This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Nov;18(11):e638.

doi: 10.1016/S1470-2045(17)30785-4. Epub 2017 Oct 31.

Concordance between plasma-based and tissue-based next-generation sequencing in LOTUS

Sung-Bae Kim¹, Rebecca Dent², Matthew J Wongchenko³, Stina M Singel³, José Baselga⁴; LOTUS investigators

Affiliations

Affiliations

¹ Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Electronic address: sbkim3@amc.seoul.kr.
² Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.
³ Genentech Inc, South San Francisco, CA 94080, USA.
⁴ Memorial Sloan Kettering Cancer Center, New York, NY, USA.

PMID: 29208392
DOI: 10.1016/S1470-2045(17)30785-4

Comment

Concordance between plasma-based and tissue-based next-generation sequencing in LOTUS

Sung-Bae Kim et al. Lancet Oncol. 2017 Nov.

. 2017 Nov;18(11):e638.

doi: 10.1016/S1470-2045(17)30785-4. Epub 2017 Oct 31.

Authors

Sung-Bae Kim¹, Rebecca Dent², Matthew J Wongchenko³, Stina M Singel³, José Baselga⁴; LOTUS investigators

Affiliations

¹ Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Electronic address: sbkim3@amc.seoul.kr.
² Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.
³ Genentech Inc, South San Francisco, CA 94080, USA.
⁴ Memorial Sloan Kettering Cancer Center, New York, NY, USA.

PMID: 29208392
DOI: 10.1016/S1470-2045(17)30785-4

Erratum in

Correction to Lancet Oncol 2017; 18: e638.
[No authors listed] [No authors listed] Lancet Oncol. 2018 Dec;19(12):e667-e668. doi: 10.1016/S1470-2045(18)30846-5. Lancet Oncol. 2018. PMID: 30507427 No abstract available.

No abstract available

PubMed Disclaimer

Comment on

Targeting PI3K/AKT pathway in triple-negative breast cancer.
Delaloge S, DeForceville L. Delaloge S, et al. Lancet Oncol. 2017 Oct;18(10):1293-1294. doi: 10.1016/S1470-2045(17)30514-4. Epub 2017 Aug 8. Lancet Oncol. 2017. PMID: 28800863 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations